The Readout Loud
Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?